UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Negative regulation of the interferon response by an interferon-induced long non-coding RNA

Nucleic acids research, 2014-09, Vol.42 (16), p.10668

2014

Volltextzugriff (PDF)

Center Experience Affects Liver Transplant Outcomes in Patients with Hilar Cholangiocarcinoma

Annals of surgical oncology, 2020-12, Vol.27 (13), p.5209-5221

2020

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.100-107.e1

2015

Volltextzugriff (PDF)

S3299 Acute Liver Injury as Initial Presentation of Adult Onset Still’s Disease

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e2098-e2098

2022

Volltextzugriff (PDF)

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation

Hepatology (Baltimore, Md.), 2015-03, Vol.61 (3), p.895-904

2015

Volltextzugriff (PDF)

Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients

The New England journal of medicine, 2016-11, Vol.375 (21), p.2106-2108

2016

Volltextzugriff (PDF)

Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD‐sodium era

Transplant international, 2021-12, Vol.34 (12), p.2856-2868

2021

Volltextzugriff (PDF)

Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes

Annals of gastroenterological surgery, 2024-05, Vol.8 (3), p.383-393

2024

Volltextzugriff (PDF)

Tu1025 A Single Center Study Evaluating Disparities in Hepatitis C Treatment Availability Based on Insurance Status

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1088-S-1088

2015

Volltextzugriff (PDF)

Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome

Clinical transplantation, 2012-09, Vol.26 (5), p.E505-E512

2012

Volltextzugriff (PDF)

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

Annals of transplantation, 2022-02, Vol.27, p.e934850-e934850-15

2022

Volltextzugriff (PDF)

Disparities in the Effects of Acuity Circle–based Liver Allocation on Waitlist and Transplant Practice Between Centers

Transplantation direct, 2022-10, Vol.8 (10), p.e1356-e1356

2022

Volltextzugriff (PDF)

Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure

Transplantation direct, 2022-02, Vol.8 (2), p.e1283-e1283

2022

Volltextzugriff (PDF)

Drug Hepatotoxicity

Clinics in liver disease, 2020-02, Vol.24 (1), p.25-35

2020

Volltextzugriff (PDF)

Sa1307 Incidence, Outcome and Factors Affecting Post Liver Transplant Cholestatic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-258-S-259

2014

Volltextzugriff (PDF)

Using biomarkers to quantify problematic alcohol use

The Journal of family practice, 2021-12, Vol.70 (10), p.474-481

2021

Volltextzugriff (PDF)

Model for end‐stage liver disease (MELD) exception for polycystic liver disease

Liver transplantation, 2006-12, Vol.12 (S3), p.S110-S111

2006

Volltextzugriff (PDF)

Novel intraoperative management in the model for end‐stage liver disease–sodium era: Continuous venovenous hemofiltration for severe hyponatremia in liver transplantation

Liver transplantation, 2018-02, Vol.24 (2), p.304-307

2018

Volltextzugriff (PDF)

Bioelectrical Impedance Analysis for the Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis C Infection

Digestive diseases and sciences, 2008-07, Vol.53 (7), p.1957-1960

2008

Volltextzugriff (PDF)

S1006 Long-Term Safety of Sirolimus in Liver Transplant Recipients

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S513-S513

2020

Volltextzugriff (PDF)

Effect of Mandatory 6‐Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2020-12, Vol.72 (6), p.2051-2062

2020

Volltextzugriff (PDF)

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

The New England journal of medicine, 2015-08, Vol.373 (8), p.714-725

2015

Volltextzugriff (PDF)

Long-term outcomes of donation after cardiac death and living donor liver transplant for primary sclerosing cholangitis

Journal of hepatology, 2022-07, Vol.77, p.S778-S779

2022

Volltextzugriff (PDF)

Transjugular intrahepatic portosystemic shunt versus balloon-occluded transvenous obliteration for the management of ectopic varices

Journal of hepatology, 2022-07, Vol.77, p.S612

2022

Volltextzugriff (PDF)

Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes

Gastroenterology (New York, N.Y. 1943), 2018-11, Vol.155 (5), p.1451-1462.e3

2018

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Humans
(47)
Liver Transplantation
(36)
Transplantation
(32)
Surgery
(30)
Gastroenterology & Hepatology
(29)
Female
(25)
Male
(25)
Adult
(21)
Middle Aged
(20)
Liver
(14)
Liver Transplantation - Adverse Effects
(14)
Biological And Medical Sciences
(12)
Liver Transplants
(12)
Risk Factors
(12)
Aged
(11)
Medical Sciences
(10)
Retrospective Studies
(10)
Transplants & Implants
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Negative regulation of the interferon response by an interferon-induced long non-coding RNA

Center Experience Affects Liver Transplant Outcomes in Patients with Hilar Cholangiocarcinoma

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

S3299 Acute Liver Injury as Initial Presentation of Adult Onset Still’s Disease

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation

Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients

Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD‐sodium era

Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes

Tu1025 A Single Center Study Evaluating Disparities in Hepatitis C Treatment Availability Based on Insurance Status

Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

Disparities in the Effects of Acuity Circle–based Liver Allocation on Waitlist and Transplant Practice Between Centers

Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure

Drug Hepatotoxicity

Sa1307 Incidence, Outcome and Factors Affecting Post Liver Transplant Cholestatic Hepatitis C

Using biomarkers to quantify problematic alcohol use

Model for end‐stage liver disease (MELD) exception for polycystic liver disease

Novel intraoperative management in the model for end‐stage liver disease–sodium era: Continuous venovenous hemofiltration for severe hyponatremia in liver transplantation

Bioelectrical Impedance Analysis for the Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis C Infection

S1006 Long-Term Safety of Sirolimus in Liver Transplant Recipients

Effect of Mandatory 6‐Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

Long-term outcomes of donation after cardiac death and living donor liver transplant for primary sclerosing cholangitis

Transjugular intrahepatic portosystemic shunt versus balloon-occluded transvenous obliteration for the management of ectopic varices

Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes

Suchergebnisse filtern